Castrate-resistant Prostate Cancer Market Trends, Share, Growth, Key Players and Future Investment Opportunities Till 2034: SPER Market Research
Castration-resistant prostate cancer (CRPC) is a type of advanced prostate cancer that is resistant to conventional hormone therapy. In CRPC, the cancer grows despite low testosterone levels in the body, which are usually the result of surgical or medicinal castration. According to SPER market research, ‘Global Castrate-resistant Prostate Cancer Market Size- By Therapy – Regional Outlook, Competitive Strategies and […]